Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$17.75 USD
-0.85 (-4.55%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $17.74 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Urogen Pharma's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
URGN 17.75 -0.85(-4.55%)
Will URGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for URGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for URGN
Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates
LENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Urogen Pharma (URGN) Reports Q1 Loss, Lags Revenue Estimates
Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?
Urogen Pharma (URGN) Reports Q4 Loss, Lags Revenue Estimates
Other News for URGN
UroGen Pharma Ltd. 2025 Q2 - Results - Earnings Call Presentation
UroGen Pharma Ltd. (URGN) Q2 2025 Earnings Call Transcript
UroGen Pharma Ltd (URGN) Q2 2025 Earnings Call Highlights: FDA Approval and Revenue Growth ...
Q2 2025 Urogen Pharma Ltd Earnings Call Transcript
UroGen Pharma reports Q2 EPS ($1.05), consensus (83c)